Dymon Asia Capital »

Immunovant shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $289k 18k 16.12

More positions owned by Dymon Asia Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Mbs Etf (MBB)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Strategy Cl A New (MSTR)
Ishares Silver Tr Ishares Call Option (SLV)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Meta Platforms Cl A Put Option (META)
Microsoft Corporation Put Option (MSFT)
Spdr Gold Tr Gold Shs Put Option (GLD)
Coinbase Global Com Cl A (COIN)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Applovin Corp Com Cl A Put Option (APP)
Vistra Energy Call Option (VST)
Broadcom Put Option (AVGO)

View all positions for Dymon Asia Capital

Top funds holding Immunovant

FMR
Deep Track Capital
Vanguard Group
Armistice Capital
BlackRock
Baker Bros. Advisors
T. Rowe Price Investment Management
Point72 Asset Management
State Street Corporation
Two Seas Capital
Alpine Partners VI
Morgan Stanley
ADAR1 Capital Management
Stempoint Capital
Geode Capital Management

View all funds holding Immunovant